Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cyclophosphamide/dactinomycin/vincristine

Tumour lysis syndrome?: case report

    • 17 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Hiraizumi Y, Kamoi S, Inde Y, Kurose K, Ohaki Y, Takeshita T.A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation. Journal of Obstetrics and Gynaecology Research 37: 947-952, No. 7, Jul 2011. Available from: URL: http://dx.doi.org/10.1111/j.1447-0756.2010.01454.x - Japan

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Cyclophosphamide/dactinomycin/vincristine. React. Wkly. 1378, 14 (2011). https://doi.org/10.2165/00128415-201113780-00044

    Download citation

    Keywords

    • Renal Function
    • Cyclophosphamide
    • Acute Renal Failure
    • Vincristine
    • Urinary Output